推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Cancer Management and Research

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER MANAG RE最新评论:审稿速度:6.0 | 投稿命中率:95.0偏重的研究方向:肿瘤;慢病管理;肿瘤康复经验分享:2023年度影响因子为2.5分 (2024-06-21)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Cancer Management and Research期刊基本信息Hello,您是该期刊的第147363位访客

基本信息 登录收藏
期刊名字Cancer Management and ResearchCancer Management and Research

CANCER MANAG RES
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.3
53人评分
我要评分

声誉
6.9

影响力
5.0

速度
9.3

期刊ISSN1179-1322
微信扫码收藏此期刊
2023-2024最新影响因子
(数据来源于搜索引擎)
2.5 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:1.942
2023-2024自引率0.00%点击查看自引率趋势图
五年影响因子2.8
JCI期刊引文指标 0.59
h-index 32
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
7.400.6750.668
学科分区排名百分位
大类:Medicine
小类:Oncology
Q191 / 404

期刊简介
Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include:

◦Epidemiology, detection and screening
◦Cellular research and biomarkers
◦Identification of biotargets and agents with novel mechanisms of action
◦Optimal clinical use of existing anticancer agents, including combination therapies
◦Radiation and surgery
◦Palliative care
◦Patient adherence, quality of life, satisfaction

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.
期刊官方网站https://www.dovepress.com/cancer-management-and-research-journal
期刊投稿网址https://www.dovepress.com/submit_step_1.php
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Cancer Management and Research的语言要求,还能让Cancer Management and Research编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Cancer Management and Research编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(1篇) 论文致谢(8篇)
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2990; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:epidemiology、cancer、anticancer agents、cancer screening、palliative care
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752
出版商Dove Medical Press Ltd.
涉及的研究方向Medicine-Oncology
出版国家或地区UNITED STATES
出版语言English
出版周期
出版年份0
年文章数 111点击查看年文章数趋势图
Gold OA文章占比96.28%
研究类文章占比:
文章 ÷(文章 + 综述)
67.57%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ3183/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ3180/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:预警等级:中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区4区2区
ONCOLOGY
肿瘤学
3区1区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区4区1区
ONCOLOGY
肿瘤学
4区2区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区4区
ONCOLOGY
肿瘤学
2区3区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1179-1322%5BISSN%5D
平均审稿速度网友分享经验:
16 Weeks
平均录用比例网友分享经验:
版面费/APC文章处理费信息
文章处理费:需要( USD2990; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Cancer Management and Research顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Cancer Management and Research期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Cancer Management and Research中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Cancer Management and Research上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Nature Cancer031.10
    JAMA Oncology4137.50
    JAMA Oncology6137.50
    Trends in Cancer028.50
    Liver Cancer2520.80
    Experimental Hematology & Oncology012.60
    ESMO Open011.70
    Cancer Biology & Medicine299.80
    Annual Review of Cancer Biology014.50
    Cancers538.00
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE677320
    BIOMATERIALS567016
    BIOMEDICINE & PHARMACOTHERAPY551721
    Frontiers in Pharmacology515525
    Journal of Materials Chemistry B506403
    Frontiers in Immunology492230
    COMPUTERS IN BIOLOGY AND MEDICINE474054
    JOURNAL OF ETHNOPHARMACOLOGY466427
    COLLOIDS AND SURFACES B-BIOINTERFACES438646
    Frontiers in Oncology436282
  •  

    Cancer Management and Research Cancer Management and Research
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma

    Author: Zhang, Guojun; Yang, Chuan; Zhao, Caixia; Xian, Feng; Qing, Dong; Guo, Qiyu; Song, Junmei; Liu, Xilin; Bie, Jun
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 101-112. DOI: 10.2147/CMAR.S395191
        PubMed      DOI
    2.Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?

    Author: Yang, Mingyu; Li, Meng; Lyu, Zhuozhen; Yang, Zhen
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 335-342. DOI: 10.2147/CMAR.S406150
        PubMed      DOI
    3.Enhanced Glycolysis Confers Resistance Against Photon but Not Carbon Ion Irradiation in Human Glioma Cell Lines

    Author: Vashishta, Mohit; Kumar, Vivek; Guha, Chandan; Wu, Xiaodong; Dwarakanath, Bilikere S.
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 1-16. DOI: 10.2147/CMAR.S385968
        PubMed      DOI
    4.TP63 Functions as a Tumor Suppressor Regulated by GAS5/miR-221-3p Signaling Axis in Human Non-Small Cell Lung Cancer Cells

    Author: Shen, Qiming; Wang, Haoyou; Zhang, Lin
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 217-231. DOI: 10.2147/CMAR.S387781
        PubMed      DOI
    5.The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma

    Author: Pan, Qianqian; Wei, Mingjing; Lu, Mengyi; Xu, Yaping; Xie, Xing; Li, Xiao
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 233-243. DOI: 10.2147/CMAR.S385974
        PubMed      DOI
    6.Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs

    Author: Mu, Fengchun; Fan, Bingjie; Li, Butuo; Qin, Wenru; Li, Haoqian; Wang, Chunni; Zou, Bing; Wang, Shijiang; Wang, Linlin
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 351-362. DOI: 10.2147/CMAR.S404874
        PubMed      DOI
    7.Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report

    Author: Liu, Zhisheng; Zhang, Junling; Ge, Yunjie; Huang, Mengli; Wang, Ye
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 197-201. DOI: 10.2147/CMAR.S397711
        PubMed      DOI
    8.Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma

    Author: Liu, Yinqiang; Duan, Jin; Zhang, Fujun; Liu, Fanghao; Luo, Xiaoyu; Shi, Yunfei; Lei, Youming
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 147-163. DOI: 10.2147/CMAR.S384918
        PubMed      DOI
    9.Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer

    Author: Liu, Xiu; Ma, Xiaoting; Ou, Kai; Wang, Qi; Gao, Lizhen; Yang, Lin
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 277-289. DOI: 10.2147/CMAR.S398539
        PubMed      DOI
    10.Determination of pressure difference coefficient of shuttle elevator doors in super high-rise buildings under stack effect

    Author: Liu, Chengxuan; Xiong, Weijian; Song, Jing; Ouyang, Xiaoqin; Fu, Yang
    Journal: CANCER MANAGEMENT AND RESEARCH. 2023; Vol. 15, Issue , pp. 131-145. DOI: 10.2147/CMAR.S394100
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Energy Material Advances013.80
    Journal of High Energy Astrophysics119.70
    VIEW012.60
    HARVARD BUSINESS REVIEW01.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.90
    ACM Transactions on Intelligent Systems and Technology469.30
    Journal of the American Nutrition Association02.50
    TRANSACTIONS OF TIANJIN UNIVERSITY012.50
    Machine Intelligence Research06.70
    Molecular Biomedicine06.30
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共1073


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室